Currently out of the existing stock ratings of Allen Lutz, 18 are a BUY (41.86%), 22 are a HOLD (51.16%), 3 are a SELL (6.98%).

Allen Lutz

Work Performance Price Targets & Ratings Chart

Analyst Allen Lutz, currently employed at BAML, carries an average stock price target met ratio of 43.85% that have a potential upside of 11.71% achieved within 74 days.

Allen Lutz’s has documented 85 price targets and ratings displayed on 7 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on HQY, HealthEquity at 13-Nov-2024.

Wall Street Analyst Allen Lutz

Analyst best performing recommendations are on DOCS (DOXIMITY).
The best stock recommendation documented was for DOCS (DOXIMITY) at 8/9/2023. The price target of $24 was fulfilled within 2 days with a profit of $1.3 (5.14%) receiving and performance score of 25.69.

Average potential price target upside

HQY HealthEquity TDOC Teladoc DOCS Doximity AMWL American Well Corp OWLT Owlet DH Definitive Healthcare Corp OMCL Omnicell

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$105

$10.05 (10.58%)

$92

11 days ago
(10-Dec-2024)

11/12 (91.67%)

$9.61 (10.07%)

249

Buy

$120

$25.05 (26.38%)

$105

19 days ago
(02-Dec-2024)

15/19 (78.95%)

$18.34 (18.04%)

199

Buy

$120

$25.05 (26.38%)

$100

1 months 8 days ago
(13-Nov-2024)

10/13 (76.92%)

$25.2 (26.58%)

85

Buy

$103

$8.05 (8.48%)

$88

3 months 17 days ago
(04-Sep-2024)

16/16 (100%)

$20.34 (24.61%)

183

Buy

$110

$15.05 (15.85%)

$107

6 months 1 days ago
(20-Jun-2024)

6/8 (75%)

$27.74 (33.72%)

697

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

Which stock is Allen Lutz is most bullish on?

Potential upside of $25.05 has been obtained for HQY (HEALTHEQUITY)

Which stock is Allen Lutz is most reserved on?

Potential downside of -$12.83 has been obtained for DOCS (DOXIMITY)

What Year was the first public recommendation made by Allen Lutz?

On 2018

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?